Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets

Journal of Laboratory and Clinical Medicine

Volumn 127, Issue 3, 1996, Pages 287-295

  Mehta, J L ^a   Chen, L Y ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; SEROTONIN;

ARTICLE; BLOOD; DRUG EFFECT; HUMAN; METABOLISM; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ARGININE; BLOOD PLATELETS; CHOLESTEROL; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; NITRIC OXIDE SYNTHASE; PLATELET AGGREGATION; SEROTONIN;

EID: 0030092041     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90097-9     Document Type: Article

References (35)

1. Moncada S, Higgs EA, Palmer RMJ. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43: 109-42.
2. Palinski W, Rosenfeld ME, Herttuala SY, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372-6.
3. Chin JH, Azhar S, Huffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992;89:10-8.
4. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by rysolecithin in modified low-density lipoproteins. Nature 1990;344:160-2.
5. Russell R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
6. Aviram M, Brook JG. The effect of human plasma on platelet function in familial hypercholesterolemia. Thromb Res 1982; 26:101-9.
7. Carvallho ACA, Colman RW, Lecs RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974;290:434-8.
8. Hassall DG, Owen JS, Bruckdorfer KR. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Biochem J 1983;216:43-9.
9. Koller E, Vukovich T. Doleschel W, Auerswald W. The influence of lipoproteins on ADP-induced platelet aggregation. Atherogenesis 1979;4(suppl IV):53-8.
10. Fuhrman B, Brook GJ, Aviram M. Activated platelets secrete a protein-like factor that stimulates oxidized-LDL receptor activity in macrophages. J Lipid Res 1991;32:1113-23.
11. Henriksen T, Evensen SA, Carlander B. Injury to cultured endothelial cells induced by low density lipoproteins: protection by high density lipoproteins. Scand J Clin Lab Invest 1979;39:369-75.
12. Matsuda Y, Hirata K, Inoue N, et al. High density lipoproteins reverse inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res 1993;72:1103-9.
13. Schmidt K, Graier WF, Kostner GM, Kukovetz WR. High density lipoprotein antagonizes the inhibitory effect of oxidized low density lipoprotein and lysolecithin on soluble guanylyl cyclase. Biochem Biophys Res Commun 1992;182: 302-8.
14. Ameli S, Hultgardh-Nilsson A, Cercek B, et al. Recombinant apolipoprotein A-1 Milano reduces intimai thickening after balloon injury in hypercholesterolemic rabbits. Circulation 1994;90:1935-42.
15. Mellion BT, Ignarro J, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981;57:946-55.
16. Durante W, Kroll MH, Vanhoutte PM, Schafer AI. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood 1992;79:110-6.
17. Nakane M, Schmidt HHHW, Pollock JS, Forstennann U, Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEES Lett 1993;316:175-80.
18. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992;267:14519-22.
19. Mehta JL, Chen LY, Kone BC, Mehta P, Turner P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J LAB CLIN MED 1995;25:370-7.
20. Mehta JL, Bryant JL Jr., Mehta P. Oxidized-LDL decreases nitric oxide synthase activity in human neutrophils. Reversal of the effect of oxidized-LDL by HDL and L-arginine. Biochem Pharmacol 1995;50:1181-5.
21. Steinbrecher VP, Witztum JL, Parthasarathy S, Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Arteriosclerosis 1987;7: 135-43.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 1976;72:248-54.
23. Chen LY, Mehta JL. Lys- and glu-plasminogen potentiate the inhibitory effect of recombinant tissue plasminogen activator on human platelet aggregation. Thromb Res 1994;74: 555-63.
24. Nicolini FA, Wilson AC, Mehta P, Mehta JL. Comparative platelet inhibitory effects of human neutrophils and lymphocytes. J LAB CLIN MED 1990;116:147-52.
25. Zlatski A, Zak B, Boyle AJ. A new method for the direct determination of serum cholesterol. J LAB CLIN MED 1953; 41:486-92.
26. Chen LY, Mehta JL. Inhibitory effect of high density lipoprotein on platelet function is mediated by increase in nitric oxide synthase activity in platelets. Life Sci 1994;55: 1815-21.
27. 15N]nitrate in biological fluids. Ann Biochem 1982;126: 131-8.
28. Schmilz G, Brüning T, Williamson E, Nowicka G. The role of HDL in reverse cholesterol transport and its disturbances in rangier disease and HDL deficiency with xanthomas. Eur Heart J 1990;11(suppl E):197-211.
29. Radomski MW, Palmer RMJ, Moncada S. An L-argininenitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-7.
30. Yang X, Cai B, Sciacca RR, Cannon PJ. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Circ Res 1994;74:318-28.
31. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low density lipoprotein decreases the expression of endothelial nitric oxide synthase expression. J Biol Chem 1995;270:319-24.
32. + RNA. Biochem Biophys Res Commun 1989;160: 705-10.
33. Aviram M, Fuhrman B, Keidar S, et al. Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation. J Clin Chem Clin Biochem 1989;27:3-12.
34. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta 1990;1044:275-83.
35. Lefer AM. Prostacyclin, high density lipoproteins and myocardial ischemia. Circulation 1990;81:2013-5.